GW Pharmaceuticals | CashCropToday
GW Pharma’s New Compound GWP42006 Fails Initial Trial Testing
Health
242 views
Health
242 views

GW Pharma’s New Compound GWP42006 Fails Initial Trial Testing

Editor - February 22, 2018

On February 21, 2018 GW Pharmaceuticals PLC (Nasdaq:GWPH) (“GW,”) announced that a Phase 2a proof of concept study of a pipeline compound GWP42006 in adult patients with…

Will GW Pharmaceuticals Shape How Cannabis is Viewed in the U.S.?
Market Watch
127 views
Market Watch
127 views

Will GW Pharmaceuticals Shape How Cannabis is Viewed in the U.S.?

kristen fisher - February 2, 2018

GW Pharmaceuticals is a Salisbury, England company who are utilizing U.S. patents to secure cannabis are a functioning medical treatment drug. Because these U.S. patents can be…